Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Windtree Therapeutics Inc (WINT) USD0.001

Sell:$1.90 Buy:$1.92 Change: $0.01 (0.53%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Sell:$1.90
Buy:$1.92
Change: $0.01 (0.53%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Deal now
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Sell:$1.90
Buy:$1.92
Change: $0.01 (0.53%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company's technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant. The Company's core development program, AEROSURF (lucinactant for inhalation), is focused on improving the management of respiratory distress syndrome (RDS) in premature infants, a respiratory condition that can result in long-term respiratory problems, developmental delay and death.

Contact details

Address:
2600 Kelly Rd Ste 100
WARRINGTON
18976-3652
United States
Telephone:
+1 (215) 4889300
Website:
www.windtreetx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
WINT
ISIN:
US97382D3035
Market cap:
$50.47 million
Shares in issue:
26.70 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Craig Fraser
    President, Chief Executive Officer, Director
  • John Hamill
    Chief Financial Officer, Senior Vice President, Corporate Secretary
  • Eric Curtis
    Chief Operating Officer, Senior Vice President
  • Joseph Soffer
    Executive Vice President - Clinical Development
  • Diane Carman
    Senior Vice President, General Counsel
  • Steven Simonson
    Senior Vice President, Chief Medical Officer
  • Randall White
    Vice President - Clinical Program Management

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.